Interferon gamma enhances clonal expansion and survival of CD4+ T cells

Journal of Interferon and Cytokine Research

Volumn 28, Issue 10, 2008, Pages 611-622

  Reed, Jennifer M ^a,b   Branigan, Patrick J ^a   Bamezai, Anil ^a  

^a VILLANOVA UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE R; STAT1 PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; LYMPHOCYTE CLONE; MOUSE; NONHUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; EIF-2 KINASE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; STAT1 TRANSCRIPTION FACTOR;

EID: 54249149865     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0145     Document Type: Article

References (64)

1. Autenrieth I, Beer M, Bohn E, Kaufmann S, Heesemann J. 1994. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun 62:2590-2599.
2. Bach, E, Aguet M, Schreiber R. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15:563-591.
3. Bajenoff M, Breart B, Huang AY, Qi H, Cazareth J, Braud VM, Germain RN, Glaichenhaus N. 2006. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 203:619-631.
4. Brocker, T. 1997. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J Exp Med 186:1223-1232.
5. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. 1993. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 177:213-218.
6. Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG. 2006. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 177:1416-1420.
7. Cullell-Young M, Barrachina M, Lopez-Lopez C, Gonalons E, Lloberas J, Soler C, Celada A. 2001. From transcription to cell surface expression, the induction of MHC class II I-A alpha by interferon-gamma in macrophages is regulated at different levels. Immunogenetics 53:136-144.
8. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. 2000. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 192:117-122.
9. Darnell JE Jr, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
10. Deb A, Haque SJ, Mogensen T, Silverman RH, Williams BR. 2001. RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J Immunol 166:6170-6180.
11. De Rose V, Cappello P, Sorbello V, Ceccarini B, Gani F, Bosticardo M, Fassio S, Novelli F. 2004. IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic, asthmatic patients by inducing Fas/FasL-mediated apoptosis. J Leuk Biol 76:423-432.
12. DeSilva DR, Jones EA, Favata MF, Jaffee BD, Magolda RL, Trzaskos JM, Scherle PA. 1998. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J Immunol 160:4175-4181.
13. Durbin J, Hackenmiller R, Simon M, Levy D. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450.
14. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11:173-181.
15. Foulds KE, Wu CY, Seder RA. 2006. Th1 memory: implications for vaccine development. Immunol Rev 211:58-66.
16. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M. 2006. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol Biol Rev 70:1032-1060.
17. Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci USA 98:6680-6685.
18. Gough DJ, Sabapathy K, Ko EY, Arthur HA, Schreiber RD, Trapani JA, Clarke CJ, Johnstone JW. 2007. A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes. J Biol Chem 282:938-946.
19. Grammer A, Fischer R, Lee O, Zhang X, Lipsky P. 2004. Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals. Arthritis Res Ther 6:28-38.
20. Haring JS, Harty JT. 2006. Aberrant contraction of antigen-specific CD4 T cells after infection in the absence of gamma interferon or its receptor. Infect Immun 74:6252-6263.
21. Havell EA, Spitalny GL, Patel PJ. 1982. Enhanced production of murine interferon gamma by T cells generated in response to bacterial infection. J Exp Med 156:112-127.
22. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745.
23. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, Kwan S, Menon S, Seymour B, Jackson C, Kung TT, Brieland JT, Zurawski SM, Chapman RW, Zurawski G, Coffman RL. 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 169:443-453.
24. Igarashi K, Garotta G, Ozmen L, Ziemiecki A, Wilks AF, Harpur AG, Larner AC, Finbloom DS. 1994. Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. J Biol Chem 269:14333-14336.
25. Kaempfer R. 2003. RNA sensors: novel regulators of gene expression. EMBO 4: 1043-1047.
26. King DP, Jones PP. 1983. Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon. J Immunol 131:315-318.
27. Kirberg J, Berns A, von Boehmer H. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 186:1269-1275.
28. Lee SK, Surh CD. 2005. Role of interleukin-7 in bone and T-cell homeostasis. Immunol Rev 208:169-180.
29. Leonard W, O'Shea J. 1998. Jaks and STATs: biological implications. Annu Rev Immunol 16:293-322.
30. Liesenfeld O, Kosek JC, Suzuki Y. 1997. Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii. Infect Immun 65:4682-4689.
31. Liu Y, Janeway Jr. CA. 1990. Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med 172:1735-1739.
32. Maraskovsky E, Teepe M, Morrissey PJ, Braddy S, Miller RE, Lynch DH, Peschon JJ. 1996. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J Immunol 157:5315-5323.
33. Marrack P, Mitchell T, Bender J, Hildeman D, Kedl R, Teague K, Kappler K. 1998. T-cell survival. Immunol Rev 165:279-285.
34. Martin-Fontecha A, Thomsen L, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5:1260-1265.
35. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan, JK. Riley DH, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442.
36. lo thymocytes in vivo. Science 250:1720-1723.
37. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL. 2000. Signaling and transcription in T helper development. Annu Rev Immunol 18:451-494.
38. Murray R, Suda T, Wrighton N, Lee F, Zlotnik A. 1989. IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol 1:526-531.
39. Naora H, Gougeon ML. 1999. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression. Cell Death Differ 6:1002-1011.
40. Narimatsu M, Maeda H, Itoh S, Atsumi T, Ohtani T, Nishida K, Itoh M, Kamimura D, Park S-J, Mizuno K, Miyazaki J, Hibi M, Ishihara K, Nakajima K, Hirano T. 2001. Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol Cell Biol 21:6615-6625.
41. Novelli F, D'Elios MM, Bernabei P, Ozmen L, Rigamonti L, Almerigogna F, Forni G, Del Prete G. 1997. Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clones. J Immunol 159:206-213.
42. Pearl JE, Saunders B, Ehlers S, Orme IM, Cooper AM. 2001. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. Cell Immunol 211:43-50.
43. Ramana C, Gil M, Schreiber R, Stark G. 2002. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23:96-101.
44. Ramana CV, Kumar A, Enelow R. 2005. Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts. Biochem Biophys Res Commun 327:727-733.
45. Refaeli Y, Van Parijs L, Alexander SI, Abbas AK. 2002. Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med 196:999-1005.
46. Rosenzweig SD, Holland SM. 2005. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 203:38-47.
47. Sato N, Yahata T, Santa K, Ohta A, Ohmi Y, Habu S, Nishimura TTT. 1996. Functional characterization of NK1.1 + Ly-6C+ cells. Immunol Lett 54:5-9.
48. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163-189.
49. Scott P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147:3149-3155.
50. Shuai K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ, Darnell JE. 1993. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366:580-583.
51. Silvennoinen O, Ihle JN, Schlessinger J, Levy DE. 1993. Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature 366:583-585.
52. Tabibzadeh SS, Satyaswaroop PG, Rao PN. 1988. Antiproliferative effect of interferon-gamma in human endometrial epithelial cells in vitro: potential local growth modulatory role in endometrium. J Clin Endocrinol Metab 67: 131-138.
53. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 98:8732-8737.
54. Tanabe Y, Nishibori T, Su L, Arduini RM, Baker DP, David M. 2005. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-α, -β Responses in T Lymphocytes. J Immunol 174:609-613.
55. Tanaka H, Samuel CE. 1994. Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc Natl Acad Sci USA 91:7995-7999.
56. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 95:3810-3815.
57. Viret C, Wong FS, Janeway Jr. CA. 1999. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity 10:559-568.
58. Wallach D. 1982. Regulation of susceptibility to natural killer cells' cytotoxicity and regulation of HLA synthesis: differing efficacies of alpha, beta, and gamma interferons. J Interferon Res 2:329-338.
59. + T cell responses. J Immunol 175:5624-5628.
60. Warner SJ, Friedman GB, Libby P. 1989. Immune interferon inhibits proliferation and induces 2′-5′-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J Clin Invest 83:1174-1182.
61. Watling D, Guschin D, Muller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, Schindler C, Stark GR, Ihle JN. 1993. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 366:166-170.
62. Weston SA, Parish CR. 1990. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 133:87-97.
63. + T cell responses. J Immunol 175:5624-5628.
64. Wong GH, Clark-Lewis I, McKimm-Breschkin L, Harris AW, Schrader JW. 1983. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol 131:788-793.